Bio­gen of­floads near­ly $600M in Cam­bridge re­al es­tate — mak­ing room for a Broad In­sti­tute ex­pan­sion

The fall­out of the Covid-19 pan­dem­ic is still play­ing out more than two and a half years af­ter it be­gan, and the newest ef­fects im­pact­ing the bio­phar­ma in­dus­try fall di­rect­ly on re­al es­tate.

Re­al es­tate de­vel­op­er BXP said Wednes­day that it ac­quired a build­ing in Cam­bridge, MA from Bio­gen for $592 mil­lion. The build­ing, lo­cat­ed at 125 Broad­way in Cam­bridge, MA, is in Cam­bridge’s biotech hub in Kendall Square, home to oth­er com­pa­nies such as Ther­mo Fish­er Sci­en­tif­ic and Mod­er­na.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.